About thinkMolecular
thinkMolecular is a company based in Bengaluru (India) founded in 2020 by Ramesh Sistla. It operates as a B2B. The company has 1 employees as of March 31, 2023. thinkMolecular offers products and services including Target Identification and Validation, Hit Generation, Lead Generation, Lead Optimization, and Chemical Biology. thinkMolecular operates in a competitive market with competitors including Owkin, Formation Bio, AbSci, BigHat and Predictive Oncology, among others.
- Headquarter Bengaluru, India
- Employees 1 as on 31 Mar, 2023
- Founders Ramesh Sistla
-
Sectors
TechnologyHealthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Thinkmolecular Technologies Private Limited
- Date of Incorporation 01 Aug, 2020
- Jurisdiction Bengaluru, Karnataka, India
-
Annual Revenue
$125.53 K (USD)256.99as on Mar 31, 2023
-
Net Profit
$49.71 K (USD)1167.42as on Mar 31, 2023
-
EBITDA
$83.46 K (USD)565.33as on Mar 31, 2023
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
1
as on Mar 31, 2023
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of thinkMolecular
thinkMolecular offers a comprehensive portfolio of products and services, including Target Identification and Validation, Hit Generation, Lead Generation, Lead Optimization, and Chemical Biology.
Analyzes data to identify and validate drug targets for informed profiles.
Screens compounds using CADD for identifying potential hits.
Optimizes hits into leads via design and selectivity techniques.
Enhances leads focusing on activity, DMPK, and adverse event mitigation.
Designs experiments based on molecular structures for target issues.
Funding Insights of thinkMolecular
Detailed funding history for thinkMolecular
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by thinkMolecular
Investment portfolio details for thinkMolecular
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - thinkMolecular
Detailed financials for thinkMolecular
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Thinkmolecular Comparisons
Peer comparison for thinkMolecular
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of thinkMolecular
thinkMolecular operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Owkin, Formation Bio, AbSci, BigHat and Predictive Oncology, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
An agentic AI platform is developed for biomedical research insights.
|
|
| Locked | Locked | Locked |
AI-powered drug discovery platform for various diseases
|
|
| Locked | Locked | Locked |
AI-based technology is used for recombinant protein production in therapeutics.
|
|
| Locked | Locked | Locked |
Antibody therapies are developed through machine learning and synthetic biology.
|
|
| Locked | Locked | Locked |
AI-based platform for cancer diagnostics and precision medicine is utilized.
|
|
| Locked | Locked | Locked |
AI platform used for extracting antibody data from scientific papers.
|
Detailed competitors of thinkMolecular
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Thinkmolecular
Complete news archive for thinkMolecular
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about thinkMolecular
thinkMolecular was founded in 2020.
thinkMolecular is headquartered in Bengaluru, India. It is registered at Bengaluru, Karnataka, India.
As of Mar 31, 2023, the latest employee count at thinkMolecular is 1.
Annual revenue of thinkMolecular is $125.53K as on Mar 31, 2023.
Think Molecular specializes in molecular simulations to advance drug discovery processes. They use AI and machine learning to analyze genomic and structural data for tasks like target identification, hit generation, and lead optimization. The company provides services such as chemical biology experiments and scientific due diligence, primarily targeting pharmaceutical entities. Based in India, they enable efficient decision-making through computational tools and consultations.
thinkMolecular's top competitors include Owkin, Formation Bio and XtalPi.
thinkMolecular offers Target Identification and Validation, Hit Generation, Lead Generation, Lead Optimization, and Chemical Biology.